4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001387131-20-001050
Chief Strategy Officer sold 300,000 shares at $2.26 ($676,920)
- Chief Strategy Officer acquired 300,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krassan Mitchell Chief Strategy Officer | 2020-02-03 | Option exercise | +105,703 | $0.19 | $19,809 | 105,703 | D: show line 1 in the form |
| Krassan Mitchell Chief Strategy Officer | 2020-02-03 | Option exercise | +194,297 | $0.20 | $39,578 | 300,000 | D: show line 2 in the form |
| Krassan Mitchell Chief Strategy Officer | 2020-02-03 | Sale | −300,000 | $2.26 | $676,920 | 0 | D: show line 3 in the form |
| Open-market sales · 300,000 sh · avg $2.26 · $676,920 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krassan Mitchell Chief Strategy Officer | 2020-02-03 | Option exercise · Non-Qualified Stock Option (right to buy) | −105,703 | 0 | D: show line 4 in the form | ||
| Krassan Mitchell Chief Strategy Officer | 2020-02-03 | Option exercise · Non-Qualified Stock Option (right to buy) | −194,297 | 489,658 | D: show line 5 in the form |
Loading xslF345X03/krassan-form4_020320.xml…